Contineum Therapeutics, Inc. CTNM
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Continua Therapeutics Inc. is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions. Its primary function lies in advancing novel drug candidates aimed at addressing unmet medical needs within the healthcare sector. The company emphasizes research and development, …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees51
TickerCTNM
Statistics
Market Cap$465.3M
Revenue (TTM)—
Net Income-$60.0M
Net Margin—
EPS$-2.17
P/E26.00
P/S—
P/B1.78
EV/EBITDA-3.07
ROE-26.9%
Dividend Yield—
Price$12.45
Data: Twelve Data · Revenue = mcap / P/S